Since GSK-3β is also strongly implicated in AD and PD 75, 76, alterations to GSK-3β activity may be a common mechanism for disrupting the VAPB–PTPIP51 tethers and ER–mitochondria associations in at least some forms of neurodegenerative disease. Here, GSK3B is linked to neurodegenerative disease.